

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of apoptotic cell clearance (GO:2000425) | 9.49604283 |
| 2 | regulation of integrin activation (GO:0033623) | 9.24816068 |
| 3 | mannose metabolic process (GO:0006013) | 8.09376591 |
| 4 | complement activation, alternative pathway (GO:0006957) | 7.26068980 |
| 5 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 7.25499198 |
| 6 | apoptotic cell clearance (GO:0043277) | 6.80709096 |
| 7 | lipoxygenase pathway (GO:0019372) | 6.77362898 |
| 8 | endothelial cell chemotaxis (GO:0035767) | 5.96407587 |
| 9 | citrulline biosynthetic process (GO:0019240) | 5.88712856 |
| 10 | germinal center formation (GO:0002467) | 5.53479021 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.48760724 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.48760724 |
| 13 | regulation of endothelial cell chemotaxis (GO:2001026) | 5.38570739 |
| 14 | negative regulation of granulocyte differentiation (GO:0030853) | 5.27896716 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.91678377 |
| 16 | complement activation (GO:0006956) | 4.87175198 |
| 17 | leukotriene metabolic process (GO:0006691) | 4.73983127 |
| 18 | opsonization (GO:0008228) | 4.66484194 |
| 19 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 4.47814549 |
| 20 | regulation of T cell chemotaxis (GO:0010819) | 4.36658906 |
| 21 | positive regulation of T cell chemotaxis (GO:0010820) | 4.36658906 |
| 22 | regulation of complement activation (GO:0030449) | 4.34197668 |
| 23 | cellular extravasation (GO:0045123) | 4.32426546 |
| 24 | positive regulation of Rap GTPase activity (GO:0032854) | 4.15156969 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07030694 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 4.03633488 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.02525245 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.99734204 |
| 29 | regulation of macrophage chemotaxis (GO:0010758) | 3.99685458 |
| 30 | primary alcohol catabolic process (GO:0034310) | 3.97084751 |
| 31 | regulation of phagocytosis (GO:0050764) | 3.96895417 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.95310100 |
| 33 | regulation of humoral immune response (GO:0002920) | 3.94049626 |
| 34 | positive regulation of chemokine secretion (GO:0090197) | 3.92583891 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.84197632 |
| 36 | detection of bacterium (GO:0016045) | 3.82550193 |
| 37 | complement activation, classical pathway (GO:0006958) | 3.79968011 |
| 38 | detection of other organism (GO:0098543) | 3.78118585 |
| 39 | citrulline metabolic process (GO:0000052) | 3.77593770 |
| 40 | icosanoid biosynthetic process (GO:0046456) | 3.77566602 |
| 41 | fatty acid derivative biosynthetic process (GO:1901570) | 3.77566602 |
| 42 | leukotriene biosynthetic process (GO:0019370) | 3.77025028 |
| 43 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.74384962 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74208123 |
| 45 | positive thymic T cell selection (GO:0045059) | 3.72474081 |
| 46 | protein activation cascade (GO:0072376) | 3.69684216 |
| 47 | adaptation of signaling pathway (GO:0023058) | 3.66655927 |
| 48 | detection of molecule of bacterial origin (GO:0032490) | 3.60930116 |
| 49 | response to peptidoglycan (GO:0032494) | 3.57791338 |
| 50 | leukocyte tethering or rolling (GO:0050901) | 3.55819573 |
| 51 | regulation of chemokine secretion (GO:0090196) | 3.55357159 |
| 52 | regulation of T cell migration (GO:2000404) | 3.53242059 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.49168553 |
| 54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49168553 |
| 55 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46001204 |
| 56 | thymic T cell selection (GO:0045061) | 3.43987385 |
| 57 | regulation of Rap GTPase activity (GO:0032317) | 3.40924449 |
| 58 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.36777082 |
| 59 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.32170436 |
| 60 | ethanol metabolic process (GO:0006067) | 3.31465763 |
| 61 | chronic inflammatory response (GO:0002544) | 3.30424323 |
| 62 | defense response to fungus (GO:0050832) | 3.27127477 |
| 63 | ethanol oxidation (GO:0006069) | 3.26770759 |
| 64 | positive regulation of antigen processing and presentation (GO:0002579) | 3.25606505 |
| 65 | cytokine production involved in immune response (GO:0002367) | 3.22826306 |
| 66 | negative thymic T cell selection (GO:0045060) | 3.22477443 |
| 67 | viral transcription (GO:0019083) | 3.20744842 |
| 68 | positive regulation of phagocytosis (GO:0050766) | 3.19402428 |
| 69 | T cell selection (GO:0045058) | 3.19171232 |
| 70 | cyclooxygenase pathway (GO:0019371) | 3.14079392 |
| 71 | positive regulation of cholesterol efflux (GO:0010875) | 3.10126748 |
| 72 | leukocyte aggregation (GO:0070486) | 3.09830008 |
| 73 | negative regulation of interleukin-6 production (GO:0032715) | 3.08848628 |
| 74 | protein carboxylation (GO:0018214) | 3.06001950 |
| 75 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.06001950 |
| 76 | detection of external biotic stimulus (GO:0098581) | 3.04882341 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03122374 |
| 78 | unsaturated fatty acid biosynthetic process (GO:0006636) | 3.02185069 |
| 79 | regulation of cholesterol storage (GO:0010885) | 3.01204611 |
| 80 | translational termination (GO:0006415) | 3.00220325 |
| 81 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98569211 |
| 82 | modulation by symbiont of host defense response (GO:0052031) | 2.98569211 |
| 83 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98569211 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98569211 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98569211 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 2.98569211 |
| 87 | neutrophil activation involved in immune response (GO:0002283) | 2.98285683 |
| 88 | negative T cell selection (GO:0043383) | 2.97682913 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94064468 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 2.93401166 |
| 91 | production of molecular mediator of immune response (GO:0002440) | 2.90561892 |
| 92 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.90194132 |
| 93 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.89988374 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 2.88430854 |
| 95 | positive regulation of T cell migration (GO:2000406) | 2.86674407 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86638597 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.86302012 |
| 98 | positive regulation of cholesterol transport (GO:0032376) | 2.84523150 |
| 99 | positive regulation of sterol transport (GO:0032373) | 2.84523150 |
| 100 | positive T cell selection (GO:0043368) | 2.84412110 |
| 101 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.84373462 |
| 102 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83110779 |
| 103 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.81699605 |
| 104 | arachidonic acid metabolic process (GO:0019369) | 2.80057756 |
| 105 | regulation of mast cell degranulation (GO:0043304) | 2.79805696 |
| 106 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78696581 |
| 107 | lymphocyte chemotaxis (GO:0048247) | 2.77917774 |
| 108 | hyaluronan catabolic process (GO:0030214) | 2.77868874 |
| 109 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.77422277 |
| 110 | leukocyte cell-cell adhesion (GO:0007159) | 2.76450217 |
| 111 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.76044654 |
| 112 | phospholipid efflux (GO:0033700) | 2.75795696 |
| 113 | pinocytosis (GO:0006907) | 2.75612072 |
| 114 | regulation of antigen processing and presentation (GO:0002577) | 2.75378830 |
| 115 | detection of biotic stimulus (GO:0009595) | 2.74328946 |
| 116 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.73783710 |
| 117 | histone H3-K36 demethylation (GO:0070544) | 2.73377332 |
| 118 | phagocytosis (GO:0006909) | 2.72674674 |
| 119 | regulation of ARF GTPase activity (GO:0032312) | 2.72330545 |
| 120 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.71326154 |
| 121 | ribosomal small subunit assembly (GO:0000028) | 2.70808741 |
| 122 | positive regulation of hemostasis (GO:1900048) | 2.70590765 |
| 123 | positive regulation of blood coagulation (GO:0030194) | 2.70590765 |
| 124 | regulation of T cell tolerance induction (GO:0002664) | 2.70570669 |
| 125 | B cell receptor signaling pathway (GO:0050853) | 2.70455111 |
| 126 | peptidyl-arginine modification (GO:0018195) | 2.69034547 |
| 127 | regulation of respiratory burst (GO:0060263) | 2.67315765 |
| 128 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.67136389 |
| 129 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.66920811 |
| 130 | negative regulation of innate immune response (GO:0045824) | 2.66913886 |
| 131 | positive regulation of coagulation (GO:0050820) | 2.66612036 |
| 132 | macrophage activation involved in immune response (GO:0002281) | 2.65009177 |
| 133 | negative regulation of myotube differentiation (GO:0010832) | 2.64831250 |
| 134 | lymph node development (GO:0048535) | 2.64752565 |
| 135 | positive regulation of B cell differentiation (GO:0045579) | 2.64733517 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63389931 |
| 137 | regulation of cell adhesion mediated by integrin (GO:0033628) | 2.62897593 |
| 138 | response to laminar fluid shear stress (GO:0034616) | 2.61221139 |
| 139 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.60960393 |
| 140 | regulation of necroptotic process (GO:0060544) | 2.59950912 |
| 141 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57847089 |
| 142 | negative regulation of T cell mediated immunity (GO:0002710) | 2.57282655 |
| 143 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.56241280 |
| 144 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.55932822 |
| 145 | regulation of tolerance induction (GO:0002643) | 2.54237615 |
| 146 | response to type I interferon (GO:0034340) | 2.52288384 |
| 147 | regulation of extracellular matrix disassembly (GO:0010715) | 2.49861329 |
| 148 | phospholipid scrambling (GO:0017121) | 2.49438995 |
| 149 | tolerance induction (GO:0002507) | 2.49375283 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.48565729 |
| 151 | type I interferon signaling pathway (GO:0060337) | 2.48565729 |
| 152 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.47206455 |
| 153 | signal complex assembly (GO:0007172) | 2.46187685 |
| 154 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.43760492 |
| 155 | negative regulation of type 2 immune response (GO:0002829) | 2.42139554 |
| 156 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37906048 |
| 157 | defense response to protozoan (GO:0042832) | 2.37409324 |
| 158 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36438450 |
| 159 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35262758 |
| 160 | regulation of B cell differentiation (GO:0045577) | 2.32194504 |
| 161 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.31599546 |
| 162 | T cell migration (GO:0072678) | 2.31110833 |
| 163 | activation of JUN kinase activity (GO:0007257) | 2.28439796 |
| 164 | regulation of necrotic cell death (GO:0010939) | 2.26996569 |
| 165 | regulation of ARF protein signal transduction (GO:0032012) | 2.26803471 |
| 166 | regulation of regulated secretory pathway (GO:1903305) | 2.26190334 |
| 167 | regulation of granulocyte differentiation (GO:0030852) | 2.25443337 |
| 168 | modulation by symbiont of host cellular process (GO:0044068) | 2.24521854 |
| 169 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.24377414 |
| 170 | response to host (GO:0075136) | 2.24040382 |
| 171 | response to host defenses (GO:0052200) | 2.24040382 |
| 172 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.24040382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.07363071 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.88529287 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.83719263 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.79464646 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71851837 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.62875027 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.62033702 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.54907391 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.46876855 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33531293 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.27609170 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14924654 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10843079 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.10052741 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.07227719 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04662001 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02619492 |
| 18 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.02611124 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01906100 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96232344 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.88008224 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87216589 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85812496 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84587175 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81837976 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80335803 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78488847 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.78485833 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76390386 |
| 30 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75978201 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72826577 |
| 32 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68305934 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66533211 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.65423484 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64352142 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62052908 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61149054 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58669875 |
| 39 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58174795 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.56928568 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56142922 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55844838 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54584557 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52044901 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51287342 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45263617 |
| 47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45003049 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.44039927 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41487817 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41454245 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41408986 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40258292 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38485443 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37766883 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.37516044 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37159830 |
| 57 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37030583 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36876187 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35745792 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31925760 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31537684 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31173585 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31080468 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31020566 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29812874 |
| 66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28458716 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27860189 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.26340590 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.22444756 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.22439360 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22438229 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22270095 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22116824 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21764525 |
| 75 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20247265 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18694428 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18316711 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17338059 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16854336 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16788283 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15759066 |
| 82 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15582760 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15092412 |
| 84 | * P68_20966046_ChIP-Seq_HELA_Human | 1.14997897 |
| 85 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14899955 |
| 86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14561353 |
| 87 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13905840 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13610180 |
| 89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12762011 |
| 90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12433354 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.11451823 |
| 92 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.10550073 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10221169 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09511636 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09090072 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08678679 |
| 97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08408602 |
| 98 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07908579 |
| 99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07006271 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06362960 |
| 101 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.05627089 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05449175 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04737843 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04044111 |
| 105 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03625744 |
| 106 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03103712 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02685888 |
| 108 | MYB_26560356_Chip-Seq_TH2_Human | 1.02299183 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02259268 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01751600 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01653800 |
| 112 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00876373 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00804487 |
| 114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00532071 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00159444 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99320433 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99131161 |
| 118 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99021074 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98645276 |
| 120 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98333842 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 0.98203473 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97190140 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96582283 |
| 124 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95861332 |
| 125 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95516341 |
| 126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95197073 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93591569 |
| 128 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93458443 |
| 129 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.93013332 |
| 130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92980961 |
| 131 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92330261 |
| 132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91508672 |
| 133 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90835428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.28091365 |
| 2 | MP0009840_abnormal_foam_cell | 3.81021689 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.75976609 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.62623118 |
| 5 | MP0008004_abnormal_stomach_pH | 2.51801833 |
| 6 | MP0003436_decreased_susceptibility_to | 2.48597324 |
| 7 | MP0005451_abnormal_body_composition | 2.47116903 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.41538132 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.35662651 |
| 10 | MP0003724_increased_susceptibility_to | 2.33697227 |
| 11 | MP0000685_abnormal_immune_system | 2.24084464 |
| 12 | MP0004947_skin_inflammation | 2.22794164 |
| 13 | MP0001790_abnormal_immune_system | 2.14216861 |
| 14 | MP0005387_immune_system_phenotype | 2.14216861 |
| 15 | MP0008260_abnormal_autophagy | 2.13571235 |
| 16 | MP0001849_ear_inflammation | 2.10284268 |
| 17 | MP0003075_altered_response_to | 2.04829827 |
| 18 | MP0005025_abnormal_response_to | 1.98424632 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.94237432 |
| 20 | MP0005360_urolithiasis | 1.94169971 |
| 21 | MP0000490_abnormal_crypts_of | 1.89467567 |
| 22 | MP0002419_abnormal_innate_immunity | 1.84001650 |
| 23 | MP0002396_abnormal_hematopoietic_system | 1.83015198 |
| 24 | MP0005671_abnormal_response_to | 1.81329603 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.75322655 |
| 26 | MP0003303_peritoneal_inflammation | 1.73478135 |
| 27 | MP0005670_abnormal_white_adipose | 1.71754775 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.70684299 |
| 29 | MP0001800_abnormal_humoral_immune | 1.68389952 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.67481331 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.66776307 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.63481523 |
| 33 | MP0001873_stomach_inflammation | 1.62943139 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.61238643 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.61068213 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.56005679 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.52582751 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.47296484 |
| 39 | MP0003828_pulmonary_edema | 1.46519367 |
| 40 | MP0001851_eye_inflammation | 1.46513826 |
| 41 | MP0004858_abnormal_nervous_system | 1.45806783 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.45216053 |
| 43 | MP0000858_altered_metastatic_potential | 1.44976234 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.44591440 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.44431520 |
| 46 | MP0002405_respiratory_system_inflammati | 1.42889812 |
| 47 | MP0000604_amyloidosis | 1.42120531 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.40728027 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.38663578 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.38502750 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.37094994 |
| 52 | MP0005023_abnormal_wound_healing | 1.36948311 |
| 53 | MP0005409_darkened_coat_color | 1.34600859 |
| 54 | MP0001819_abnormal_immune_cell | 1.34478004 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.32619871 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.32445195 |
| 57 | MP0001915_intracranial_hemorrhage | 1.32269378 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.29084809 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.28725283 |
| 60 | MP0006054_spinal_hemorrhage | 1.27959508 |
| 61 | MP0001663_abnormal_digestive_system | 1.27480585 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 1.26397808 |
| 63 | MP0002722_abnormal_immune_system | 1.25880999 |
| 64 | MP0002254_reproductive_system_inflammat | 1.25508076 |
| 65 | MP0002723_abnormal_immune_serum | 1.23582107 |
| 66 | MP0005365_abnormal_bile_salt | 1.23468540 |
| 67 | MP0004510_myositis | 1.23228274 |
| 68 | MP0000716_abnormal_immune_system | 1.20170432 |
| 69 | MP0005166_decreased_susceptibility_to | 1.18853009 |
| 70 | MP0009278_abnormal_bone_marrow | 1.18571330 |
| 71 | MP0003091_abnormal_cell_migration | 1.17497153 |
| 72 | MP0006082_CNS_inflammation | 1.15738263 |
| 73 | MP0000249_abnormal_blood_vessel | 1.14107815 |
| 74 | MP0002009_preneoplasia | 1.13527360 |
| 75 | MP0002132_abnormal_respiratory_system | 1.13347356 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.13264754 |
| 77 | MP0000609_abnormal_liver_physiology | 1.12770201 |
| 78 | MP0002398_abnormal_bone_marrow | 1.10913111 |
| 79 | MP0009763_increased_sensitivity_to | 1.09707768 |
| 80 | MP0005666_abnormal_adipose_tissue | 1.09696603 |
| 81 | MP0002429_abnormal_blood_cell | 1.09400123 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 1.09156487 |
| 83 | MP0004130_abnormal_muscle_cell | 1.06522286 |
| 84 | MP0005310_abnormal_salivary_gland | 1.06423429 |
| 85 | MP0004019_abnormal_vitamin_homeostasis | 1.06034923 |
| 86 | MP0000678_abnormal_parathyroid_gland | 1.05439397 |
| 87 | MP0005397_hematopoietic_system_phenotyp | 1.05269062 |
| 88 | MP0001545_abnormal_hematopoietic_system | 1.05269062 |
| 89 | MP0005375_adipose_tissue_phenotype | 1.05140880 |
| 90 | MP0008469_abnormal_protein_level | 1.04935031 |
| 91 | MP0009379_abnormal_foot_pigmentation | 1.03847698 |
| 92 | MP0002136_abnormal_kidney_physiology | 1.02297933 |
| 93 | MP0001853_heart_inflammation | 1.01689132 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 1.01536945 |
| 95 | MP0005174_abnormal_tail_pigmentation | 1.00992592 |
| 96 | MP0004381_abnormal_hair_follicle | 0.99411129 |
| 97 | MP0000477_abnormal_intestine_morphology | 0.98104161 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.96903813 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.96889744 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.95725148 |
| 101 | MP0003279_aneurysm | 0.95009904 |
| 102 | MP0001666_abnormal_nutrient_absorption | 0.92711946 |
| 103 | MP0004272_abnormal_basement_membrane | 0.92514632 |
| 104 | MP0000751_myopathy | 0.89698158 |
| 105 | MP0003866_abnormal_defecation | 0.89621333 |
| 106 | MP0005381_digestive/alimentary_phenotyp | 0.89369464 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.89316164 |
| 108 | MP0009785_altered_susceptibility_to | 0.89073005 |
| 109 | MP0000598_abnormal_liver_morphology | 0.88702844 |
| 110 | MP0003690_abnormal_glial_cell | 0.86777735 |
| 111 | MP0004808_abnormal_hematopoietic_stem | 0.85860776 |
| 112 | MP0005165_increased_susceptibility_to | 0.85821768 |
| 113 | MP0003329_amyloid_beta_deposits | 0.85310959 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84334226 |
| 115 | MP0005390_skeleton_phenotype | 0.83945693 |
| 116 | MP0002060_abnormal_skin_morphology | 0.83183658 |
| 117 | MP0002933_joint_inflammation | 0.82955807 |
| 118 | MP0002971_abnormal_brown_adipose | 0.82882446 |
| 119 | MP0003763_abnormal_thymus_physiology | 0.82716110 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.82016130 |
| 121 | MP0003045_fibrosis | 0.81861447 |
| 122 | MP0002006_tumorigenesis | 0.80220427 |
| 123 | MP0002138_abnormal_hepatobiliary_system | 0.79421979 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.79162252 |
| 125 | MP0000733_abnormal_muscle_development | 0.77688572 |
| 126 | MP0005083_abnormal_biliary_tract | 0.77310978 |
| 127 | MP0003448_altered_tumor_morphology | 0.76984330 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.75861729 |
| 129 | MP0004883_abnormal_blood_vessel | 0.74091435 |
| 130 | MP0009764_decreased_sensitivity_to | 0.73452195 |
| 131 | MP0006138_congestive_heart_failure | 0.73448042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glomerulonephritis (HP:0000099) | 7.05976805 |
| 2 | Abnormality of complement system (HP:0005339) | 6.32216089 |
| 3 | Complement deficiency (HP:0004431) | 6.16306977 |
| 4 | Dysostosis multiplex (HP:0000943) | 5.71817019 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.27768736 |
| 6 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.44619168 |
| 7 | Mucopolysacchariduria (HP:0008155) | 4.44619168 |
| 8 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.14157802 |
| 9 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.14157802 |
| 10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.14157802 |
| 11 | Nephritis (HP:0000123) | 4.11583107 |
| 12 | Shallow orbits (HP:0000586) | 4.04165244 |
| 13 | Pustule (HP:0200039) | 3.98995226 |
| 14 | Asymmetric septal hypertrophy (HP:0001670) | 3.92632236 |
| 15 | Cerebral aneurysm (HP:0004944) | 3.76970426 |
| 16 | Spondylolisthesis (HP:0003302) | 3.52549523 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32488379 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.24054373 |
| 19 | Loss of speech (HP:0002371) | 3.22474260 |
| 20 | Joint stiffness (HP:0001387) | 3.21842408 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.20817344 |
| 22 | Myositis (HP:0100614) | 3.16298450 |
| 23 | Prolonged bleeding time (HP:0003010) | 3.14970715 |
| 24 | Nasal polyposis (HP:0100582) | 3.13730336 |
| 25 | Increased IgE level (HP:0003212) | 3.08714695 |
| 26 | Cervical subluxation (HP:0003308) | 3.07617214 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 2.95589647 |
| 28 | Abnormality of the fingertips (HP:0001211) | 2.87231257 |
| 29 | Menorrhagia (HP:0000132) | 2.85530105 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.76012009 |
| 31 | Orchitis (HP:0100796) | 2.71700445 |
| 32 | Thin bony cortex (HP:0002753) | 2.71048233 |
| 33 | Malnutrition (HP:0004395) | 2.69363543 |
| 34 | Cellulitis (HP:0100658) | 2.68168496 |
| 35 | Exercise-induced myalgia (HP:0003738) | 2.67748412 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 2.67658954 |
| 37 | Thoracic kyphosis (HP:0002942) | 2.67505666 |
| 38 | Polygenic inheritance (HP:0010982) | 2.67454593 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.66035810 |
| 40 | Peritonitis (HP:0002586) | 2.62004911 |
| 41 | Eczematoid dermatitis (HP:0000976) | 2.60468928 |
| 42 | Hemorrhage of the eye (HP:0011885) | 2.58392463 |
| 43 | J-shaped sella turcica (HP:0002680) | 2.58134623 |
| 44 | Bronchomalacia (HP:0002780) | 2.56280935 |
| 45 | Periodontitis (HP:0000704) | 2.55414563 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53037028 |
| 47 | Obstructive lung disease (HP:0006536) | 2.53037028 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.52923429 |
| 49 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.52486416 |
| 50 | Meningitis (HP:0001287) | 2.48445012 |
| 51 | Deformed sella turcica (HP:0002681) | 2.46950781 |
| 52 | Hand muscle atrophy (HP:0009130) | 2.46755131 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.42944771 |
| 54 | Flat acetabular roof (HP:0003180) | 2.37323391 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35311681 |
| 56 | Esophageal varix (HP:0002040) | 2.34537242 |
| 57 | Wrist flexion contracture (HP:0001239) | 2.32043830 |
| 58 | Recurrent bacterial skin infections (HP:0005406) | 2.31446087 |
| 59 | Increased connective tissue (HP:0009025) | 2.30431094 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29359460 |
| 61 | Optic neuritis (HP:0100653) | 2.29224295 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.29224295 |
| 63 | Abnormality of the thoracic spine (HP:0100711) | 2.28704238 |
| 64 | Distal lower limb amyotrophy (HP:0008944) | 2.26326674 |
| 65 | Myopathic facies (HP:0002058) | 2.22389346 |
| 66 | Recurrent skin infections (HP:0001581) | 2.21100949 |
| 67 | IgM deficiency (HP:0002850) | 2.19043227 |
| 68 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.17866344 |
| 69 | Prolonged partial thromboplastin time (HP:0003645) | 2.17466534 |
| 70 | Abnormality of the lumbar spine (HP:0100712) | 2.16907805 |
| 71 | Amyloidosis (HP:0011034) | 2.15723247 |
| 72 | Enlarged penis (HP:0000040) | 2.15259234 |
| 73 | Impaired platelet aggregation (HP:0003540) | 2.14554745 |
| 74 | Abnormal platelet function (HP:0011869) | 2.14554745 |
| 75 | Vasculitis (HP:0002633) | 2.14153213 |
| 76 | Chest pain (HP:0100749) | 2.13202600 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.11431390 |
| 78 | Colitis (HP:0002583) | 2.10921691 |
| 79 | Coarse hair (HP:0002208) | 2.08207178 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 2.07398676 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.06617308 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06541215 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06541215 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.06457913 |
| 85 | Multifactorial inheritance (HP:0001426) | 2.06289001 |
| 86 | Epistaxis (HP:0000421) | 2.05655183 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.05387112 |
| 88 | Emphysema (HP:0002097) | 2.04541216 |
| 89 | Broad metatarsal (HP:0001783) | 2.04273734 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 2.02642417 |
| 91 | Vertebral hypoplasia (HP:0008417) | 2.02229451 |
| 92 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.02229451 |
| 93 | Severe short stature (HP:0003510) | 2.01640632 |
| 94 | Reticulocytopenia (HP:0001896) | 2.01135625 |
| 95 | Easy fatigability (HP:0003388) | 2.00282091 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 10.0824908 |
| 97 | Neurofibrillary tangles (HP:0002185) | 1.98524681 |
| 98 | Ovoid vertebral bodies (HP:0003300) | 1.98477409 |
| 99 | Metaphyseal cupping (HP:0003021) | 1.97982462 |
| 100 | Increased serum ferritin (HP:0003281) | 1.97213395 |
| 101 | Spontaneous hematomas (HP:0007420) | 1.96631932 |
| 102 | Arterial tortuosity (HP:0005116) | 1.95683812 |
| 103 | Hypertriglyceridemia (HP:0002155) | 1.95480985 |
| 104 | Toxemia of pregnancy (HP:0100603) | 1.93545390 |
| 105 | Purpura (HP:0000979) | 1.93377752 |
| 106 | Broad face (HP:0000283) | 1.92572610 |
| 107 | Axonal loss (HP:0003447) | 1.92553034 |
| 108 | Hemoptysis (HP:0002105) | 1.91942518 |
| 109 | Encephalitis (HP:0002383) | 1.91734706 |
| 110 | Thrombocytosis (HP:0001894) | 1.91632431 |
| 111 | Arthropathy (HP:0003040) | 1.91358523 |
| 112 | Beaking of vertebral bodies (HP:0004568) | 1.90076572 |
| 113 | Cerebral inclusion bodies (HP:0100314) | 1.89989719 |
| 114 | Upper limb amyotrophy (HP:0009129) | 1.89626909 |
| 115 | Distal upper limb amyotrophy (HP:0007149) | 1.89626909 |
| 116 | Distal lower limb muscle weakness (HP:0009053) | 1.89610309 |
| 117 | 11 pairs of ribs (HP:0000878) | 1.88958164 |
| 118 | Agammaglobulinemia (HP:0004432) | 1.88580653 |
| 119 | Petechiae (HP:0000967) | 1.87582754 |
| 120 | Global brain atrophy (HP:0002283) | 1.87312941 |
| 121 | Aneurysm (HP:0002617) | 1.87000922 |
| 122 | Abnormal hemoglobin (HP:0011902) | 1.86520492 |
| 123 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86067007 |
| 124 | Pathologic fracture (HP:0002756) | 1.85836271 |
| 125 | Large eyes (HP:0001090) | 1.85379829 |
| 126 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85285515 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85285515 |
| 128 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85285515 |
| 129 | Osteomyelitis (HP:0002754) | 1.84266106 |
| 130 | Abnormality of macrophages (HP:0004311) | 1.82432633 |
| 131 | Stridor (HP:0010307) | 1.82174242 |
| 132 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82119205 |
| 133 | Milia (HP:0001056) | 1.81960611 |
| 134 | Pulmonary infiltrates (HP:0002113) | 1.81623074 |
| 135 | Restrictive lung disease (HP:0002091) | 1.81498345 |
| 136 | Gingivitis (HP:0000230) | 1.81290352 |
| 137 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.80578737 |
| 138 | Personality changes (HP:0000751) | 1.79602886 |
| 139 | Seborrheic dermatitis (HP:0001051) | 1.78683070 |
| 140 | Onion bulb formation (HP:0003383) | 1.78204661 |
| 141 | Difficulty running (HP:0009046) | 1.78111415 |
| 142 | Urethral obstruction (HP:0000796) | 1.77860691 |
| 143 | Short nail (HP:0001799) | 1.77089626 |
| 144 | Polycythemia (HP:0001901) | 1.76803948 |
| 145 | Joint hemorrhage (HP:0005261) | 1.75982695 |
| 146 | Xanthomatosis (HP:0000991) | 1.75614718 |
| 147 | Abnormality of the sella turcica (HP:0002679) | 1.73424205 |
| 148 | Disinhibition (HP:0000734) | 1.73127096 |
| 149 | Verrucae (HP:0200043) | 1.72595940 |
| 150 | Papilloma (HP:0012740) | 1.72595940 |
| 151 | Recurrent fungal infections (HP:0002841) | 1.72559501 |
| 152 | Neuronal loss in central nervous system (HP:0002529) | 1.71859286 |
| 153 | Right ventricular cardiomyopathy (HP:0011663) | 1.71472891 |
| 154 | Ulnar deviation of the wrist (HP:0003049) | 1.71292115 |
| 155 | Agnosia (HP:0010524) | 1.71092154 |
| 156 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.70937755 |
| 157 | Recurrent viral infections (HP:0004429) | 1.67698953 |
| 158 | Turricephaly (HP:0000262) | 1.65767548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 5.54915688 |
| 2 | ERN1 | 3.53237704 |
| 3 | PRPF4B | 3.35914317 |
| 4 | PKN2 | 2.98334065 |
| 5 | TGFBR2 | 2.96945144 |
| 6 | MAP4K1 | 2.87604975 |
| 7 | TRIB3 | 2.82291096 |
| 8 | CAMK1D | 2.71698008 |
| 9 | EEF2K | 2.64803561 |
| 10 | MET | 2.61909981 |
| 11 | BLK | 2.57970748 |
| 12 | DAPK2 | 2.36931370 |
| 13 | MAP3K10 | 2.31789707 |
| 14 | TAOK3 | 2.16315393 |
| 15 | BMX | 2.07087983 |
| 16 | FGFR4 | 2.06003512 |
| 17 | STK10 | 1.99988217 |
| 18 | GRK6 | 1.97716685 |
| 19 | RIPK1 | 1.94593078 |
| 20 | MAP3K11 | 1.81819531 |
| 21 | TNK2 | 1.81524974 |
| 22 | TYK2 | 1.78138750 |
| 23 | CAMK1G | 1.76376583 |
| 24 | SMG1 | 1.71345654 |
| 25 | PTK6 | 1.64648641 |
| 26 | MAP2K3 | 1.63438375 |
| 27 | MAP3K14 | 1.58773471 |
| 28 | CDC42BPA | 1.52353487 |
| 29 | MARK2 | 1.45870749 |
| 30 | CSF1R | 1.44571909 |
| 31 | ZAP70 | 1.38450151 |
| 32 | FES | 1.34135882 |
| 33 | EPHB1 | 1.32178453 |
| 34 | LMTK2 | 1.30875931 |
| 35 | EPHA2 | 1.26738102 |
| 36 | CLK1 | 1.19423638 |
| 37 | NEK2 | 1.19017685 |
| 38 | FGR | 1.18518579 |
| 39 | LRRK2 | 1.15957829 |
| 40 | TBK1 | 1.15563964 |
| 41 | EPHB2 | 1.14688297 |
| 42 | CSK | 1.13826853 |
| 43 | TAOK1 | 1.13604544 |
| 44 | SIK3 | 1.08638251 |
| 45 | SCYL2 | 1.07051588 |
| 46 | FGFR3 | 1.05613554 |
| 47 | RPS6KA4 | 1.05081630 |
| 48 | IKBKE | 1.02371561 |
| 49 | MAP2K6 | 0.97386272 |
| 50 | MAP3K7 | 0.97119308 |
| 51 | MAP2K2 | 0.96988485 |
| 52 | PRKD2 | 0.96538410 |
| 53 | DAPK1 | 0.96286879 |
| 54 | PAK4 | 0.96085506 |
| 55 | NME2 | 0.96063251 |
| 56 | RPS6KB2 | 0.91575459 |
| 57 | HCK | 0.91210907 |
| 58 | MAPK7 | 0.87865631 |
| 59 | TTN | 0.87398455 |
| 60 | KSR2 | 0.87097955 |
| 61 | BTK | 0.85457344 |
| 62 | SIK2 | 0.83405877 |
| 63 | MAPKAPK3 | 0.82296478 |
| 64 | ITK | 0.81801379 |
| 65 | KDR | 0.77291655 |
| 66 | HIPK2 | 0.74717294 |
| 67 | LCK | 0.74629689 |
| 68 | CDK12 | 0.74102870 |
| 69 | TYRO3 | 0.73500234 |
| 70 | PDGFRA | 0.72479943 |
| 71 | CDK4 | 0.71876999 |
| 72 | JAK2 | 0.71784480 |
| 73 | DYRK1B | 0.71348555 |
| 74 | TAOK2 | 0.69631769 |
| 75 | MATK | 0.69379522 |
| 76 | TGFBR1 | 0.67882721 |
| 77 | BCKDK | 0.67415285 |
| 78 | MAP3K13 | 0.66157964 |
| 79 | MTOR | 0.66069034 |
| 80 | CAMKK1 | 0.65993802 |
| 81 | JAK1 | 0.65365709 |
| 82 | PRKCH | 0.64969983 |
| 83 | MAP3K8 | 0.64326845 |
| 84 | RIPK4 | 0.62964718 |
| 85 | MAPK12 | 0.61564065 |
| 86 | RPS6KC1 | 0.61110492 |
| 87 | RPS6KL1 | 0.61110492 |
| 88 | RPS6KA2 | 0.60996233 |
| 89 | STK38 | 0.60001044 |
| 90 | RPS6KA6 | 0.58637281 |
| 91 | CDK6 | 0.56588112 |
| 92 | TXK | 0.56093294 |
| 93 | DDR2 | 0.55975220 |
| 94 | MAPK15 | 0.54550724 |
| 95 | MAP3K6 | 0.53752211 |
| 96 | MAPK11 | 0.53249976 |
| 97 | PRKG2 | 0.53027527 |
| 98 | SYK | 0.51392574 |
| 99 | SIK1 | 0.51377457 |
| 100 | PTK2 | 0.49863591 |
| 101 | MARK3 | 0.49268832 |
| 102 | IGF1R | 0.48683080 |
| 103 | IRAK2 | 0.46150812 |
| 104 | PDGFRB | 0.46040547 |
| 105 | EIF2AK1 | 0.45091144 |
| 106 | EGFR | 0.44589053 |
| 107 | PRKAA2 | 0.44309152 |
| 108 | TLK1 | 0.43546493 |
| 109 | MAP3K2 | 0.43356294 |
| 110 | NME1 | 0.42708187 |
| 111 | IRAK1 | 0.42481862 |
| 112 | IRAK4 | 0.41442126 |
| 113 | SGK3 | 0.39990535 |
| 114 | RET | 0.39961184 |
| 115 | IRAK3 | 0.39422164 |
| 116 | PIK3CG | 0.39164482 |
| 117 | FLT3 | 0.38896395 |
| 118 | KIT | 0.38349489 |
| 119 | MOS | 0.37847807 |
| 120 | DAPK3 | 0.37665432 |
| 121 | MAP3K1 | 0.37539279 |
| 122 | ICK | 0.36598257 |
| 123 | CHUK | 0.35720074 |
| 124 | EPHA3 | 0.35376109 |
| 125 | IKBKB | 0.34738098 |
| 126 | CAMK4 | 0.34173001 |
| 127 | MAP3K3 | 0.34155679 |
| 128 | PDK1 | 0.32982220 |
| 129 | LYN | 0.32370523 |
| 130 | JAK3 | 0.32294829 |
| 131 | FYN | 0.31224608 |
| 132 | ERBB2 | 0.30761860 |
| 133 | PDPK1 | 0.30390170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.90263380 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.21941110 |
| 3 | * Other glycan degradation_Homo sapiens_hsa00511 | 3.83097879 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.65606285 |
| 5 | Pertussis_Homo sapiens_hsa05133 | 2.66212652 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.45035208 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25451556 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18951985 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14902156 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.13133650 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.05011352 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 2.01727838 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.96806115 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.94650170 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.87746746 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82418786 |
| 17 | Prion diseases_Homo sapiens_hsa05020 | 1.62789380 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.57048893 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48371996 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44154024 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.41583574 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.40648521 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36282977 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.34709300 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32148040 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28921951 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28527158 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21086387 |
| 29 | Lysine degradation_Homo sapiens_hsa00310 | 1.20834632 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19335719 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17896603 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17611755 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15515757 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14779268 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.14686014 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.14661885 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11049160 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.08488846 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07865264 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05467955 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05121949 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04165609 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02984895 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.00556066 |
| 45 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.99326073 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.98344888 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97840255 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.96928565 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95219474 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92208268 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92123261 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89735967 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89226127 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89179525 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88907121 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88386982 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87930576 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87859774 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87510837 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86912129 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86557981 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86228415 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86134266 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85909018 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85446720 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.84509995 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84341994 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83084233 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82719013 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81314498 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81011578 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.80569017 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79701352 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79200152 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78626784 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77489954 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74212098 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73565563 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70678922 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69034403 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68227214 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68020237 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67734049 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67290100 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67160719 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66738934 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66181631 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65959128 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65837679 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65738866 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65728344 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64177632 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.64129272 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62361484 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62217544 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62168940 |
| 97 | Tuberculosis_Homo sapiens_hsa05152 | 0.61937481 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60177648 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59900747 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59519231 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.59503228 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59203593 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59153132 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58941045 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55058791 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55005127 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52881702 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51409813 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51233835 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51144584 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.49845426 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49714600 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.49160720 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49077316 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48459744 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.47790818 |
| 117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47500179 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.47497543 |
| 119 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47225667 |
| 120 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47154088 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47115629 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44901540 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43936667 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.43095800 |
| 125 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42078424 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42022026 |
| 127 | DNA replication_Homo sapiens_hsa03030 | 0.39403937 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | 0.39340069 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.39170858 |
| 130 | Influenza A_Homo sapiens_hsa05164 | 0.38652689 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38110533 |
| 132 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36988329 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34597497 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33146223 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31971916 |
| 136 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.31647590 |
| 137 | Adherens junction_Homo sapiens_hsa04520 | 0.31548106 |
| 138 | Shigellosis_Homo sapiens_hsa05131 | 0.31362318 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31123518 |
| 140 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31096566 |
| 141 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29192526 |
| 142 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28969339 |
| 143 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.28011315 |
| 144 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27927774 |
| 145 | Insulin resistance_Homo sapiens_hsa04931 | 0.27589349 |
| 146 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.26305496 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.25829158 |
| 148 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.25013627 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23930514 |
| 150 | Bladder cancer_Homo sapiens_hsa05219 | 0.23874628 |
| 151 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23168322 |

